Ran Xu
- Co-authors
- Shaomeng WangYi HanChao‐Yie YangScott G. FillerDimitrios P. KontoyiannisLisa Y. ChiangRaymond H. JacobsonGeorgios Chamilos
- Topics
- Ferroptosis and cancer prognosis (3 papers)Peptidase Inhibition and Analysis (3 papers)Immunotherapy and Immune Responses (3 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEJournal of Medicinal Chemistry
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Ran Xu
22 papers receiving 649 citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 382
- Oncology 150
- Organic Chemistry 106
- Infectious Diseases 105
- Cancer Research 88
Countries citing papers authored by Ran Xu
This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).
Fields of papers citing papers by Ran Xu
This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.
Co-authorship network of co-authors of Ran Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Ran Xu. A scholar is included among the top collaborators of Ran Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Xu. Ran Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 17 | |
| 9 | 17 | |
| 10 | 28 | |
| 11 | 16 | |
| 12 | 16 | |
| 13 | 15 | |
| 14 | 28 | |
| 15 | FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer | 1 |
| 16 | 2 | |
| 17 | 6 | |
| 18 | 54 | |
| 19 | 203 | |
| 20 | 153 |
About Ran Xu
Ran Xu is a scholar working on Issues, ethics and legal aspects, Applied Microbiology and Biotechnology and Oncology, having authored 25 papers that have together received 654 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Cancer Research (88 citations), Infectious Diseases (105 citations) and Molecular Biology (382 citations). Ran Xu has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Shaomeng Wang, Yi Han, Chao‐Yie Yang, Scott G. Filler, Dimitrios P. Kontoyiannis, Lisa Y. Chiang, Raymond H. Jacobson, Georgios Chamilos, Gregory S. May and Shiqi Ren. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.